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(57) ABSTRACT 
The isolation of and methods of using a sub-genomic 
transcript (Sgt) promoter from Mirabilis mosaic virus 
(MMV) are described. A 333 bp MMV Sgt promoter frag 
ment (sequence-306 to +27 from the transcription start site, 
TSS) Was found to be sufficient for strongest promoter 
activity. This MMV Sgt promoter fragment shoWs compa 
rable promoter activity to the MMV FLt promoter both in 
transgenic plants and in protoplasts. The MMV Sgt promoter 
also demonstrates much greater activity compared to Can 
li?ower mosaic virus (CaMV) 19S promoter and 35S pro 
moter. The MMV Sgt promoter fragment and any chimeric 
gene to Which it may be linked are usefull for plant geneic 
engineering to obtain transgenic plants, plant cells and 
seeds. 
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COMPOSITION AND METHODS OF USING 
THE MIRABILIS MOSAIC CAULIMOVIRUS 
SUB-GENOMIC TRANSCRIPT (SGT) 
PROMOTER FOR PLANT GENETIC 
ENGINEERING 
This application claims priority to US. application Ser. 
No. 60/295,566, ?led Jun. 5, 2001. 
FIELD OF THE INVENTION 
This invention relates generally to plant genetic engineer 
ing and plant molecular biology. More particularly, the 
invention relates to the isolation and use of a neW plant 
promoter for driving the eXpression of plant genes. 
BACKGROUND OF THE INVENTION 
The Mirabilis mosaic virus (MMV) infects Mirabilis 
plant species (family Nyctaginaceae), a member of the 
Caulimoviridae family. The virus has a circular double 
stranded DNA genome of about 8 Kb With four single 
stranded discontinuities in the DNA, one in the alpha strand 
and three in the complementary strand The restriction 
map of the MMV genome is quite different from that of the 
other members of the genus Caulimovirus The MMV 
virus Was characteriZed as a member of the genus Cauli 
movirus based upon the morphology of its virions and 
inclusion bodies 
Recently, MMV has been fully sequenced, and homology 
analysis of its genomic DNA has shoWn that it is a de?nitive 
member of the genus Caulimovirus [Maiti, unpublished]. 
HoWever, MMV is serologically distinct from the Cauli 
?ower mosaic virus (CaMV), the type species of this genus 
[2]. 
Several Caulimoviria'ae genomes have been fully 
sequenced and characteriZed. These include Cauli?ower 
mosaic virus (CaMV) [3], Carnation etched ring virus 
(CERY) [4], Figwort mosaic virus (FMV) [5], Soybean 
chlorotic mottle virus (SoCMV) [6], Peanut chlorotic streak 
virus (PCISV) [7], Casava vein mosaic virus (CVMV) [8], 
Strawberry vein banding virus (SVBV) [9], Petunia vein 
clearing virus PVCV) [10], and Mirabilis mosaic virus 
(MMV) [Maiti, unpublished]. 
The Caulimovirus genome generally contains tWo tran 
scriptional promoters, one for the full-length transcript and 
the other for the subgenomic transcript. These transcripts are 
equivalent to the CaMV 35S and 19S transcript respectively 
[6, 11, 12]. A number of strong constitutive promoters have 
been derived from viruses of the Caulimoviridae family, 
particularly from the Cauli?ower mosaic virus (CaMV): 
CaMV35S and 19S promoter[13, 14]. Genetic promoters 
have also been isolated from other members of this family, 
namely Rice tungro bacilliform virus RTBV) [15], Com 
melina yellow mottle virus (CYMV) [16], Soybean chlorotic 
mottle virus (SoCMV) [6], Figwort mosaic virus (FMV, 
strain DXS) [17, 18]), FMV strain M3 [19], Cassava vein 
mosaic virus (CVMV) [20], Peanut cholotic streak virus 
(PClSV) [21] and Mirabilis mosaic virus (MMV) [22, 23] 
and used for the construction of plant transformation vec 
tors. Transcript promoters from Caulimoviruses, such as 
CaMV, FMV, PCISV, MMV and FMV are active in all plant 
organs [13, 18, 21—23], Whereas, transcript promoters from 
Badnaviruses, such as CYMV and RTBV are phloem 
speci?c [15, 16] in expressing genes in transgenic plants. 
The CaMV 35S promoter has been Well characteriZed [13, 
24—30] and Widely used in chimeric gene constructs for 
heterologous gene eXpression in transgenic plants [31—33]. 
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The CaMV 35S promoter is also active in bacteria [34], 
yeast [35], Hela cells [36] and Xenopus oocytes [37]. 
The eXpression of useful foreign traits in plants is a major 
focus in plant biotechnology. There is a need for a variety of 
different (e.g., constitutive, tissue speci?c and/or inducible) 
promoters that meet the different potential applications in 
this ?eld of plant genetic engineering. Introduction of het 
erologous genes of interest into plant cells generates the 
desired qualities in the plants of choice (Maiti and Hunt, 
1992; Wagner, 1992). Plant biotechnology is leading a rapid 
progress in production of economically valuable germplasm 
With improved characteristics or traits such as insect 
resistance, virus resistance, fungal resistance, herbicide 
resistance, bacterial or nematode pathogen resistance, cold 
or drought tolerance, improved nutritional value, seed oil 
modi?cation, delayed ripening of fruits, and male sterility, to 
name a feW. These germplasms provide an enhanced devel 
opment in breeding programs for crop improvement as Well 
as a better understanding of gene regulation and organiZa 
tion in transgenic plants. 
Plant metabolic engineering is the application of genetic 
engineering methods to modify the nature of chemical 
metabolites in plants. For metabolic engineering Where 
multiple genes need to be inserted into a single cell, the use 
of different strong constitutive promoters is desirable in 
order to avoid genetic instability caused by recombination 
betWeen identical or closely related promoter sequences, for 
eXample, those taken from plants themselves. Through use 
of these promoter sequences the introduced genes can be 
transcribed to messenger RNA and then translated to result 
ant proteins to exhibit neW traits or characters. 
Besides developing useful traits in crops, plant molecular 
engineering Will lead to further understanding of molecular 
pathWays involved in disease development and secondary 
metabolism in plants. Moreover, by engineering plants With 
speci?c foreign genes, the responses of plants to abiotic and 
biotic stress and stress related metabolism can be analyZed. 
Thus, there is a need in the art for plant promoters that can 
be used to drive the eXpression of genetically engineered 
genes in plants. 
SUMMARY OF THE INVENTION 
In one aspect of the invention there is provided an isolated 
DNA molecule comprising a mirabilis mosaic virus (MMV) 
subgenomic transcript (Sgt) promoter comprising the nuc 
loetide sequence of SEQ ID NO:1 or a fragment thereof 
having at least about 30% MMV Sgt promoter activity. In a 
preferred embodiment of this aspect of the invention the Sgt 
promoter is a fragment comprising the nucleotide sequence 
of —306 to +27 of SEQ ID NO:1. In another preferred 
embodiment, the MMV Sgt promoter is a fragment com 
prising the nucloetide sequence of —456 to +27 of SEQ ID 
NO:1. In a most preferred embodiment, the MMV Sgt 
promoter of the invention is operably linked to a nucleotide 
sequence Which encodes a polypeptide. In yet another pre 
ferred embodiment, the MMv Sgt promoter has the nucle 
otide sequence of SEQ ID NO:2. 
In another aspect of the invention, there is provided an 
intermediate plant transformation plasmid comprising a 
region of homology to an Agrobacterium tumefaciens gene 
vector, anAgrobacterium tumefaciens T-DNA border region 
and a chimeric gene located betWeen the T-DNA border and 
the region of homology, said chimeric gene comprising a 
MMV Sgt promoter comprising MMV Sgt promoter com 
prising the nucloetide sequence of SEQ ID NO:1 or a 
fragment thereof having at least about 30% MMV Sgt 
US 6,930,182 B1 
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promoter activity, wherein the MMV Sgt promoter or frag 
ment thereof is operably linked to a nucleotide sequence 
encoding a polypeptide. In a preferred embodiment of this 
aspect of the invention, the chimeric gene further comprises 
a MMV leader sequence operably linked to said nucleotide 
sequence. In another preferred embodiment of this aspect of 
the invention the MMV Sgt promoter comprises at least one 
enhancer domain. 
In yet another aspect of the invention, there is provided a 
plant transformation vector comprising a disarmed Agro 
bacterium tumefaciens plant tumor-inducing plasmid and a 
chimeric gene, said chimeric gene comprising a MMV Sgt 
promoter comprising the nucleotide sequence of SEQ ID 
NO: 1 or a fragment thereof having at least about 30% MMV 
Sgt promoter activity, Wherein the MMv Sgt Promoter or 
fragment thereof is operably linked to a nucleotide sequence 
encoding a polypeptide. In a preferred embodiment of this 
aspect of the invention, the MMV Promoter comprises at 
least one enhancer domain. 
In another aspect of the invention, there is provided an 
intermediate plant transformation plasmid comprising a 
region of homology to an Agrobacterium tumefaciens gene 
vector, an Agrobacterium tumefaciens T-DNA border region 
and a chimeric gene located betWeen the T-DNA border and 
the region of homology, said chimeric gene comprising a 
MMV Sgt promoter comprising the nucleotide sequence of 
SEQ ID NO:1 or a fragment thereof having at least about 
30% MMV Sgt promoter activity, Wherein the MMV Sgt 
promoter or fragment thereof is operably linked to a nucle 
otide sequence encoding a polypeptide. 
In a further aspect of the invention, there is provided a 
transgenic plant or transgenic plant part comprising a plant 
transformation vector comprising a disarmed Agrobacte 
rium tumefaciens plant tumor-inducing plasmid and a chi 
meric gene, said chimeric gene comprising a MMV Sgt 
promoter comprising the nucleotide sequence of SEQ ID 
NO: 1 or a fragment thereof having at least about 30% MMV 
Sgt promoter activity, Wherein said MMV Sgt promoter or 
fragment thereof is operably linked to a nucleotide sequence 
Which encodes a polypeptide; and Wherein said chimeric 
gene is expressed in the plant. In a preferred embodiment of 
this aspect of the invention, the chimeric gene encodes a 
plant metabolic polypeptide or a polypeptide that confers 
pathogen resistance to the transgenic plant. In another pre 
ferred embodiment, the plant part is selected from the group 
consisting of a root, leaf, stem, ?oWer petal, pollen, callus 
and cell. 
In another aspect of the invention, there is a transformed 
plant protoplast comprising a plant transformation vector 
comprising a disarmed Agrobacterium tumefaciens plant 
tumor-inducing plasmid and a chimeric gene, said chimeric 
gene comprising a MMV Sgt promoter comprising the 
nucleotide sequence of SEQ ID NO:1 or a fragment thereof 
having at least about 30% MMV Sgt promoter activity, 
Wherein said MMV Sgt promoter or fragment thereof is 
operably linked to a nucleotide sequence Which encodes a 
polypeptide. 
In yet another aspect of the invention, there is provided a 
method of making a transgenic plant comprising (1) trans 
forming a plant cell With a chimeric gene comprising a 
MMV Sgt promoter comprising the nucleotide sequence of 
SEQ ID NO:1 or a fragment thereof having at least about 
30% MMV Sgt promoter activity, Wherein said MMV Sgt 
promoter or fragment thereof is operably linked to a nucle 
otide sequence Which encodes a polypeptide; (2) culturing 
the plant cell under groWing conditions to produce a regen 
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erated plant; and (3) and expressing the chimeric gene in the 
regenerated plant. 
There is also provided a promoter enhancer element 
having the sequence set forth in SEQ ID NO: 10. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shoWs the DNA sequence of the subgenomic 
transcript promoter from mirabilis mosaic virus (MMV) 
(SEQ ID NO:1). The nucleotide sequence of the MMV Sgt 
promoter (coordinates —646 to +377 in respect of transcrip 
tion start site; corresponding coordinates in MMV genome 
4829 to 5840), and a 1023 bp fragment including the 3‘ end 
of gene V, folloWed by the small intergenic region and 5‘ 
portion of gene VI presented from left to right in the 5‘ to 3‘ 
direction of the transcript. Modi?cation of the promoter 
sequence resulted from insertion of an ‘EcoRI to Smal’ 
adapter is shoWn in loWer case. The end points for the 5‘ or 
the 3‘ deletion constructs are also indicated above or beloW 
the sequence, respectively. The TATA-box, (TATAA), CAT 
box (CAAT) and initiator AT G codon for gene VI are shoWn 
in bold. The transcriptional start site (TSS) is indicated as 
+1. 
FIG. 2 is an autoradiograph shoWing the location of the 
transcriptional start site (TSS) of the MMV Sgt promoter by 
primer extension analysis. Primer extension Was carried out 
as described in Example 4. Primer extension reaction prod 
ucts Were subjected to electrophoresis on denaturing poly 
acrylamide gel containing urea, alongside With the sequence 
reaction of GUS gene construct (lane G, A, T and C). The 
process Was performed With the same labeled primer. The 
minus strand DNA sequence read on the gel is shoWn, and 
the transcriptional start site (A*) in the corresponding plus 
strand is indicated by an arroW. 
FIGS. 3A and 3B: FIG. 3A is a schematic map of the GUS 
constructs (number 1 to 25) developed for deletion analysis 
of the MMV Sgt promoter. The coordinates of the relative 
deletion fragments are given in parenthesis. The end points 
for the 5‘ or the 3‘ deletion constructs are also indicated 
above or beloW the sequence, respectively in FIG. 1. At the 
top, the relative position of the TATA box and the MMV 
genomic coordinates are shoWn. FIG. 3B is a bar graph 
shoWing MMV Sgt promoter expression analysis in a pro 
toplast transient expression assay using a GUS reporter 
gene. Soluble protein extracts (5 pg) from transformed 
protoplasts Were used for the GUS assay. Each construct Was 
assayed at least three times in three independent experi 
ments. The average GUS activity is presented in the histo 
gram. Error bars shoW a 95% con?dence interval of the 
means. The statistical (one-Way analysis of variance, 
AN OVA) analysis shoWed an extremely signi?cant P value 
of <0.001. C., untransformed control, extract from untrans 
formed protoplast; 19S, 35S, GUS gene is directed by the 
CaMV 19S and 35S promoter, respectively. 
FIGS. 4A and B: FIG. 4A is an autoradiograph of RNA 
dot-blot analysis of total RNA (10 pg) obtained from trans 
formed protoplasts With construct No 1 to 25 as indicated in 
FIG. 3A. FIG. 4B is a Northern blot analysis of total RNA 
(10 pg) obtained from pPMS8GUS With 32P labeled GUS as 
probe (lane 2) and RNA obtained from untransformed 
Samsun NN plant (lane 1). 
FIGS. 5A and B: FIGS. 5A and 5B are a bar graphs 
shoWing comparative expression analyses of the MMV Sgt 
promoter With the MMV FLt promoters and CaMV promot 
ers (35S and 19S) in (A) transient expression in protoplasts 
and (B) stable expression in transgenic plants. 
(5A): GUS constructs: pPMS5GUS, pPMS8GUS With the 
MMV Sgt promoter; pPM1GUS, pPM12GUS and 
US 6,930,182 B1 
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pPM13GUS With MMV FLt promoter, as described ear 
lier [22]; and pPCaSGUS and pPCa35SGUS With CaMV 
19S and 35S promoters, respectively, Were assayed in 
protoplast transient expression experiments. Each con 
struct Was assayed at least three times in three indepen 
dent experiments. The average GUS activity is presented 
in the histogram. Error bars shoW a 95% con?dence 
interval on the means. The statistical ANOVA analysis 
shoWed a P value <0.001; this is considered to be 
extremely signi?cant. 
(5B): The MMV Sgt promoter (GUS-constructs 
pKMS5GUS, pKMSGUS and pKMS17GUS) and CaMV 
19 S and 35S promoter (GUS constructs pKCaSGUS and 
pKCa35SGUS respectively) Were compared. The pro 
moter activity Was measured in four-Week-old seedlings 
(R1 progeny) groWn aseptically on an MS-agar medium 
in the presence of kanamycin (200 mg/ liter) and 3% 
sucrose. Soluble protein extract from the Whole seedlings 
Were used for the GUS assay. The data are means of ?ve 
independent experiments for each construct; eight to ten 
independent transgenic lines developed for each construct 
Were assayed. The average GUS activity is presented for 
each construct in the histogram, With standard deviation 
from the mean indicated by an error bar. Error bars shoW 
a 95% con?dence interval on the means. The statistical 
AN OVA analysis indicated that the P value <0.001 means 
extremely signi?cant. Untransformed control (Control), 
tissue extract from Wild-type N. tabacum cv. SamsunNN. 
FIG. 6 is a histogram shoWing expression of MMV Sgt 
promoters in various parts (roots, R; leaves, L; stems, S) of 
four-Week-old seedlings developed for pKMS5GUS, 
pKMSSGUS and pKMS17GUS. GUS activity Was mea 
sured ?uorometrically using soluble protein extract (5 pg) 
from roots, stems and leaves of seedlings. The presented 
value in the histogram, With standard deviation indicated by 
an error bar, is the average of six samplings from each of the 
eight independent lines developed for each construct. Error 
bar shoWs a 95% con?dence interval on the means. The 
statistical ANOVA analysis shoWed that a P value <0.001 
means extremely signi?cant. 
FIG. 7 provides photographs of six transgenic plants of 
the invention. ShoWn are histochemical assays of GUS 
expression in transgenic tobacco (N. tabacum cv. Samsun 
NN) seedlings (R1 progeny, 24-day old) developed for the 
folloWing constructs: pKMS5GUS, pKMS8GUS, 
pKMS17GUS, pKCaSGUS (19S-GUS) and pKCa35SGUS 
(35S-GUS). These data Were derived from pools of trans 
formed lines With best expressing independent lines shoWn 
representing each construct. Untransformed control is 
shoWn Wild type N. tabacum Samsun NN. 
FIG. 8 provides photographs of parts of transgenic plants 
of the invention. Histochemical localiZation of GUS activity 
in developing transgenic tobacco plants expressing the GUS 
reporter gene directed by MMV Sgt promoter is shoWn. All 
sections are at 15x magni?cation. A. Samsun NN tobacco 
plant (non-transformed) as control; note no GUS staining. B. 
Matured leaf section from thirteen-Weeks-old plants (R1 
progeny) developed for the construct pKMS5GUS; note 
more GUS staining in vascular tissues (v), midrib and veins. 
C. Root from four-Week-old seedlings (pKMS5GUS, R1 
progeny) shoWing intense staining at the tip and in vascular 
(v) tissue. D. Top portion of ten-day old seedling 
(pKMS5GUS, R1 progeny); most GUS activity localiZed in 
leaves and apical meristematic region. E. Transgenic 
tobacco seedling (pKMS5GUS, R1 progeny) at day 7 after 
imbibition, groWn axenically on agar plate; GUS activity is 
localiZed primarily in root tips, root hairs and in the lower 
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hypocotyls. F and G. Transverse cross section of petiole 
from control non-transformed Samsun NN (F), no GUS 
staining; and from four Week-old seedlings (pKMS5GUS, 
R1 progeny), GUS staining is most intense in the vascular 
(v) cells H, I, J and K. Transverse cross section (H and 
I) and longitudinal cross section (J and K) of stem from four 
Week old control seedlings nontransformed Samsun NN (H 
and J respectively), note no GUS activity; and from four 
Week old transformed seedlings (pKMD5GUS, R1 
progeny); GUS activity localiZed mostly in vascular (v) 
tissues (I and L. Transverse section of tobacco ?oWer 
pedicel and ovary; M. Stigma (s) and style (St); N. Anther 
(a); and O. The petal and another (a) in ?oWer tissues 
display GUS staining. 
DETAILED DESCRIPTION OF THE 
INVENTION 
The present invention is directed to the isolation and 
characteriZation of the promoter for the subgenomic tran 
script (Sgt) from a genomic clone of mirabilis mosaic virus 
(Richins and Shepherd, 1983) as described beloW in 
Example 1, (ii) use of the MMV Sgt promoter to transform 
plant cells, plant expression vectors including a MMV Sgt 
promoter, chimeric genes including a MMV Sgt promoter 
sequence, and transgenic plants, plant cells, and plant parts, 
including seeds, Which contain the MMV Sgt promoter in a 
chimeric gene. 
Disclosed herein is the identi?cation and characteriZation 
of a subgenomic transcript (Sgt) promoter from the Mira 
bilis mosaic virus (MMV), neWly described species of the 
genus Caulimovirus. The optimal boundries required for 
maximal promoter activity and boundries that provided 
sub-maximal promoter activity have been de?ned by 5‘-and 
3‘-end delation analysis of the promoter/leader region, both 
in transgenic plants and in protoplast transient expression 
experiments. The nucleotide sequence of the MMV Sgt 
promoter, containing a 12 nucleotide insert betWeen nt —130 
and —117 is shoWn in FIG. 1 (SEQ ID NO:11). It is 
understood that the MMV Sgt promoter described herein 
does not contain the 12 nt insert in nature and that the 
isolated Sgt promoter and promoter fragments described 
herein do not require the 12 nt insert for function. The insert 
Was added for ease of manipulation of the isolated promoter 
and fragments. It is also understood, that all references to the 
nucleotide sequence of the isolated promoter and fragments 
thereof include the 12 nt insert as shoWn in FIG. 1, unless 
otherWise indicated. HoWever, the invention also encom 
passes the MMV Sgt promoter and fragments thereof that 
lack the 12 nt insert and Whose sequence numbering is 
adjusted accordingly, i.e., nt—130 is linked to nt—117. For 
example, SEQ ID NO:12 is the sequence of the MMV Sgt 
promoter from nt—646 to +377, but lacking the 12 nt insert. 
A 333 nt MMV Sgt promoter fragment (sequence —306 to 
+27 from transcription start site (SEQ ID NO:2); 321 nt 
Without the 12 nt insert shoWn in FIG. 1) (SEQ ID NO:13) 
Was found to be suf?cient for maximal promoter activity in 
a protoplast transient expression system. (FIG. 3). A larger 
promoter fragment containing nucleotides —456 to +27 
(SEQ ID NO:9) shoWed even higher activity in stably 
transformed transgenic plants. (FIG. 5). Various other Sgt 
promoter fragments that retain promoter activity, albeit at a 
loWer level than the full length or 333 bp fragment, have also 
been identi?ed. (FIG. 3). Fragment 1 (—646 to +27) is SEQ 
ID NO:14. Fragment 2 (—606 to +27) is SEQ ID NO:15. 
Fragment 3 (—556 to +27) is SEQ ID NO:16. Fragment 4 
(—506 to +27) is SEQ ID NO:17. Fragment 5 (—456 to +27) 
is SEQ ID NO:9. Fragment 6 (—406 to +27) is SEQ ID 
US 6,930,182 B1 
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NO:18. Fragment 7 (—356 to +27) is SEQ ID NO:19. 
Fragment 8 (—306 to +27) is SEQ ID NO:2. Fragment 9 
(—256 to +27) is SEQ ID NO:20. Fragment 10 (-206 to +27) 
is SEQ ID NO:21. Fragment 11 (—156 to +27) is SEQ ID 
NO:22. Fragment 12 (—117 to +27) is SEQ ID NO:23. 
Fragment 13 (—94 to +27) is SEQ ID NO:24. Fragment 14 
(—74 to +27) is SEQ ID NO:25. Fragment 15 (—44 to +27) 
is SEQ ID NO:26. Fragment 16 (—456 to —74) is SEQ ID 
NO:27. Fragment 17 (—456 to —19) is SEQ ID NO:28. 
Fragment 18 (—306 to +50) is SEQ ID NO:29. Fragment 19 
(—306 to +77) is SEQ ID NO:30. Fragment 20 (—306 to 
+127) is SEQ ID NO:31. Fragment 21 (—306 to +177) is 
SEQ ID NO:32. Fragment 22 (—306 to +227) is SEQ ID 
NO:33. Fragment 23 (—306 to +277) is SEQ ID NO:34. 
Fragment 24 (—306 to +327) is SEQ ID NO:35. Fragment 25 
(—306 to +377) is SEQ ID NO:36. 
The strength of the MMV Sgt promoter is compatible With 
the MMV FLt promoter and greater than that of the CaMV 
19S and CaMV 35S promoters. This is the ?rst report, to our 
knowledge, documenting the strong and constitutive expres 
sion characteristic of the MMV Sgt promoter. 
The MMV Sgt promoter sequence contains several regu 
latory domains found in other caulimovirus promoters: the 
TATAA sequence (coordinates —65 to —61 from the Tran 
scription Start Site (TSS) in FIG. 1) and the CAAT sequence 
(coordinates —110 to —70 from TSS in FIG. 1) located 41 bp 
upstream of the TATA box. In the MMV Sgt promoter 
sequence, an ‘as-1’-like enhancer element (TGACG; coor 
dinates —90 to —88 from TSS in FIG. 1) and an ‘as-2’-like 
motif (GATT; coordinates —145 to —142 from TSS in FIG. 
1) are located at the 22 bp and 76 bp upstream of the TATA 
box, respectively. The MMV Sgt promoter has only one 
copy of an ‘as-1’-like or ‘as-2’-like motif; Whereas, dupli 
cated copies are present in full-length transcript promoters 
of CaMV, FMV and MMV [13, 18, 22]. In addition, several 
direct repetitive sequences are present in the MMV Sgt 
promoter. These are: TCAGGA(-412 to —407 and —297 to 
—292), GAATTAC (—386 to —380 and —364 to —358), 
GGTGA (—244 to —240 and —344 to —340), CC(A/T) 
TTTTTC (—77 to —69 and —19 to —11) and AAACA (—28 to 
—24, +12 to +16, and +21 to +25) (FIG. 1). These repetitive 
sequences may have some regulatory function. 
An EcoRI site located at 48 bp upstream of the TATA 
sequence Was modi?ed to a SmaI site using a SmaI adaptor. 
This change inserted 12 additional nucleotides (5‘ 
AATTACCCCGGGC-3‘) (SEQ ID NO:11), into the MMV 
Sgt promoter sequence as shoWn in loWercase (FIG. 1),— 
but did not affect promoter activity. 
A comparison of the activity of a promoter fragment 
containing nucleotides —406 to +27 (SEQ ID NO:18) to that 
of a fragment containing nucleotides —356 to +27 (SEQ ID 
NO:19) shoWs that the inclusion of the nucleotide sequence 
from —406 to —35 6 enhances promoter activity. (FIG. 3A and 
B). Thus, it appears that the sequence —406 to —357 (SEQ ID 
NO:10) contains a promoter enhancer. This enhancer 
sequence can be used With other plant promoters to enhance 
promoter activity. For example, the enhancer sequence can 
be operably linked to a plant promoter either alone, or in 
combination With other promoter enhancer elements. Sev 
eral enhancer elements may be operably linked, preferably 
in tandem, or may be spaced apart from one another, 
depending on the particular level of activity desired. The 
enhancer element may also be used With fragments of the 
present promoter to increase activity thereof. 
In Caulimovirus, both subgenomic and full-length tran 
script promoters share the same 3‘-ends by using the same 
poly (A) signal. 
15 
20 
25 
35 
40 
45 
55 
60 
65 
8 
The transcriptional start site (TSS) of the MMV Sgt 
promoter Was determined by primer extension analysis using 
total RNA isolated from transgenic plants developed With 
the construct pKMS5GUS (FIG. 2). The major extension 
product Was detected and mapped to an adenine residue 
located 63 nucleotide doWnstream of the TATA box in the 
MMV Sgt sequence and, most likely, it represents the 5 ‘-end 
of the MMV Sgt transcript (FIG. 2). The location of the TSS 
reported for other caulimoviruses: CaMV 35S [46], 
FMV34S [47], FMV FLt [18], PCISV FLt [7] and MMV FLt 
[22] is at the 32, 37, 45, 29 and 24 nucleotides doWnstream 
of respective TATA boxes. The transcription start site of the 
MMV Sgt promoter shoWs no sequence homology With that 
of other caulimovirus promoters. 
A deletion analysis scheme of the MMV Sgt promoter is 
shoWn in FIG. 3A. A series of 5‘-and 3‘-end -deleted pro 
moter fragments (total of 25 fragments) Were included to 
map the optimal boundries required for maximal expression 
from the promoter/leader region and also to analyZe the 
in?uence of the upstream and doWnstream cis-sequences 
With respect to the TATA box. The designed deletion pro 
moter fragments 1 to 25 (FIG. 3A) Were ampli?ed by PCR 
and cloned into the expressing sites of vector 
pUCPMAGUS, as described in the Examples. Results of the 
expression analysis of the MMV Sgt promoter are shoWn in 
FIG. 3B. In a transient expression assay, construct 8 
(pPMS8GUS), Which contains the promoter fragment 
(coordinate-306 to +27 from TSS (SEQ ID NO:2)) gave 
maximum activity in protoplasts. The expression level of 5‘ 
deletion constructs 1, 2, 3 and 4 Was 6%, 5%, 9% and 5%, 
respectively relative to construct 8. This suggest that the 
upstream sequence region (coordinates —646 to —455 from 
TSS in FIG. 1) may contain repressor elements. HoWever, in 
this context, to obtain maximal promoter activity this region 
(coordinates —646 to —455 from TSS in FIG. 1) is not 
essential. The 5‘ deletion construct 5, 6 and 7 shoWed 88%, 
60% and 32% of maximal activity, respectively. In construct 
7, 5‘ deletion of 50 bp of sequence (—406 to —356 from TSS 
in FIG. 1) reduced promoter activity by 46% relative to 
construct 6 (compared construct 6 and 7) and by 63% 
relative to construct 5 (compare construct 5 and 7). These 
deletion results clearly shoW the importance of this region 
(—406 to —357 from TSS; SEQ ID NO:10) in overall 
promoter activity. There are also tWo direct repeat sequences 
GAATTC (coordinates —386 to —380, and —364 to —358 
from TSS) in this region. Although, constructs 8 With 
promoter sequences (—306 to +27 from TSS (SEQ ID 
NO:2)) shoWed maximum activity in protoplast transient 
expression experiments, construct 5 With promoter coordi 
nates (—456 to +27 from TSS (SEQ ID NO:9)) exhibited 
more activity in stable expression assay in transgenic plants. 
Constructs 9, 10 and 11 gave 42%, 37% and 29%, 
respectively, of maximal activity compared to construct 8, 
demonstrating the importance of cis sequences betWeen 
—306 to —255 from TSS, as deletion of this stretch reduced 
maximal promoter activity by 58% (compare construct 9 
With construct 8). Construct 12, containing a CAAT 
sequence (coordinates —110 to —107 from TSS in FIG. 1), 
shoWed 58% of construct 8 activity. HoWever, further dele 
tion of 22 bp (coordinates —117 to —93 from TSS in FIG. 1) 
in construct 13 (Which contains an ‘as-1’-motif) reduced 
promoter activity to 14% of that of construct 8, and to 24% 
of that of construct 12, suggesting the importance of the 
CAAT box in this region for promoter function. The 5‘ 
deletion construct 13, Which contains the ‘as-1’-motif, con 
struct 14, Which contains the TATA like element, and con 
struct 15, Which lacks a TATA region, shoWed 14%, 3% and 
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1%, respectively, of maximal activity (compare With con 
struct 8). This demonstrates the requirement of further 
additional TATAupstream sequences for full promoter activ 
ity. The 3‘ deletion-construct 16 (promoter coordinates —456 
to —74 from TSS in FIG. 1 (SEQ ID NO:27), Which is devoid 
of a TATA box shoWed no appreciable promoter activity, 
suggesting the importance of the TATAA sequence in the 
MMV Sgt promoter function. Although, the MMV Sgt 
promoter does not contain a eukaryotic consensus regulatory 
sequence, TATATAA, this result indicates that the TATAAA 
sequence in MMV Sgt promoter functions as a TATA box. 
The 3‘ deletion construct 17 (—456 to —19 in respect to TSS 
in FIG. 1 (SEQ ID NO:28)), shoWed about 33% of maximal 
promoter activity. In this context, construct 17 may produce 
transcripts With different TSS. Construct 18, 19, 20, 21, 22, 
23, 24 and 25, With successively extended 3‘ leader 
sequence, gave signi?cantly less activity (2%, 1%, 0.7%, 
9%, 0.25%, 0.3%, 0.4%, and 0.3%, respectively) of full 
promoter activity. These results suggest that, in this context, 
the longer leader sequence +50 to +378 has a signi?cant 
inhibitory effect on promoter function. 
A 333 bp MMV Sgt promoter/leader fragment, sequence 
—306 to +27 from TSS (See FIG. 1)(SEQ ID NO:2), Was 
found to be suf?cient for maximal GUS expression. In 
contrast, in the FLt promoter from FMV and MMV, an 
extended leader sequence is required for maximum promoter 
activity [18,22]. 
The relative strength of various MMV Sgt promoter 
fragments that Were operably linked to the GUS reporter 
gene Was evaluated by hybridiZation analysis of total RNA. 
Total RNA extracted from the transformed protoplasts With 
each of the constructs (No. 1 to 25, as described in FIG. 3A) 
Was used for RNA dot-blot analysis (FIG. 4A). The P32 
labeled GUS coding sequence Was used as a probe. Con 
struct 8 gave the strongest signal, and Was folloWed by 
construct 5, 6, 7, 9, 10 and 17. A minimum signal Was 
obtained from construct 16, Which is devoid of a TATA-box 
(FIG. 4A). The relative transcript level obtained With these 
constructs, in general, is in good agreement With the 
observed GUS activity. The level of transcript in constructs 
18 to 25 containing longer leader sequence (+50 to +378) 
Was relatively less, and promoter function Was reduced, 
probably through the effect of longer untranslated leader 
sequences on transcription and subsequent translation. 
Northern analysis of total RNA isolated from tobacco pro 
toplasts transformed With construct 8 shoWed a single dis 
crete band corresponding to GUS transcripts of the expected 
siZe (2100 nt) (FIG. 4B). 
The present invention provides plant expression vectors 
and intermediate transforming vectors containing the sub 
genomic transcript (Sgt) promoter from MMV. The MMV 
Sgt promoter sequence is useful for directing and expressing 
foreign genes of interest, e.g., pathogen resistance genes, 
genes encoding metabolic proteins, gene encoding stress 
resistance factors, etc., in plants to confer useful properties 
to those transgenic plants, such as pathogen or stress 
resistance, for example. For example, the MMV Sgt pro 
moter sequence may be operably linked to an insect resis 
tance gene, such as the Bt toxin gene of Bacillus 
thuringiensis, a gene encoding phenol oxidase, a proteinase 
inhibitor, an alpha-amylase inhibitor, a chitinase, lectin, 
tobacco peroxidase, VIP1 or VIP2 of Bacillus cereus, tryp 
tophan decarboxylase, cholesterol oxidase, or the Wasp 
teratocyte secretory protein (TSP 14); an herbicide resis 
tance gene, such as Mutated Acetolatate Syntase (ALS) from 
tobacco, bar gene (phosphinothricin acetyl tansferase from 
Streptomyces hygroscopius, 5-enolpyruvylshikimate-3 
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phosphate synthase, nitrilase gene (bxn) from K. ozaenae, or 
2,4-dichlorophenoxyacetate monooxygenase from the soil 
bacterium Alcaligenes eutrophus (JMP 134); a fungal resis 
tance gene, such as ribosome inhibiting proteins (RIP), 
ricin-A chain, Wheat tritin, KP4 gene, or chitinase, or 
combinations thereof. In addition, there may be a transcrip 
tional termination signal doWnstream of the coding 
sequence. 
Where inhibition of gene expression is desired in a plant, 
the MMV Sgt promoter or fragments thereof can be operably 
linked to a polynucleotide coding sequence in antisense 
orientation so that the transcribed RNA is complementary in 
sequence to MRNA of the gene Whose expression is to be 
inhibited. In addition, there may be a transcription termina 
tion sequence doWnstream of the polynucleotides directing 
synthesis of the antisense RNA. 
These vectors are useful for both direct DNA uptake by 
isolated protoplasts and Ti plasmid-mediated gene transfer. 
Thus, the invention is applicable to plant genetic engineer 
ing in general. 
For example, the MMV Sgt promoter constructs of the 
invention may comprise an intermediate plant transforma 
tion plasmid Which has a region of homology to an Agro 
bacterium tumefaciens gene vector, anAgrobacterium tume 
faciens T-DNA border region and a chimeric gene located 
betWeen the T-DNAborder and the region of homology. The 
chimeric gene prferably contains a MMV Sgt promoter of 
SEQ ID NO:1 or SEQ ID NO:12, or a fragment of SEQ ID 
NO:1 or SEQ ID NO:12 operably linked to a nucleotide 
sequence encoding a polypeptide in sense or antisense 
orientation. Fragments of the MMV Sgt promoter used in 
these constructs preferably have at least about 30% promoter 
activity (relative to the full length promoter), more prefer 
ably about 32% promoter activity, and most preferably, from 
about 60% to 100% promoter activity. The nucleotide 
sequence that is linked to the MMV Sgt promoter preferably 
encodes a heterologoud gene (heterologous relative to the 
promoter). Preferably, the construct does not include any 
sequence encoding MMV polypeptide. 
The present invention also provides plant transformation 
vectors, comprising a disarmed Agrobacterium tumefaciens 
plant tumor-inducing plasmid and a chimeric gene. The 
chimeric gene contains a MMV Sgt promoter of SEQ ID 
NO:1 or a fragment thereof having at least about 30% 
promoter activity relative to a full length promoter, prefer 
ably about 32% activity, and most preferably, about 60% to 
about 100% promoter activity. The promoter is operably 
linked to a nucleotide sequence Which encodes a 
polypeptide, preferably a heterologous peptide or polypep 
tides (relative to the MMV promoter). In another preferred 
embodiment, the chimeric gene contains a MMV Sgt pro 
moter of SEQ ID NO:12, or a fragment thereof operably 
linked to a nucleotide sequence encoding a polypeptide, 
Wherein the fragment has at least about 30% promoter 
activity relative to the full length promoter of SEQ ID 
NO:12). 
The MMV Sgt promoter-containing DNA molecules, 
plasmids and vectors of the invention can be used to 
generate stable transgenic plants or transform plant proto 
plasts. Methods for transforming plant protoplasts and gen 
erating transgenic plants are Well knoWn in the art of plant 
molecular engineering. For generating transgenic plants or 
plant protoplasts, the MMV Sgt promoter of the invention, 
Which has a nucleotide sequence of SEQ ID NO:1 or SEQ 
ID NO:12, or a fragment of SEQ ID NO:1 or SEQ ID NO:12 
that has at least about 30% promoter activity, preferably 
US 6,930,182 B1 
11 
about 32% promoter activity, more preferably about 60% 
promoter activity, and most preferably up to 100% promoter 
activity, is operably linked to an open reading frame encod 
ing a polypeptide of interest. In a preferred embodiment, the 
MMV Sgt promoter-open reading frame construct also 
includes a 5‘-leader sequence and/or a non-translated poly 
adenylation site operably linked thereto. Preferably, 
promoter-containing constructs of the invention include at 
least one enhancer domain in the promoter region, and most 
preferably, the promoter-containing constructs of the inven 
tion include tWo or more enhancer domains. 
The MMV Sgt constructs of the invention can be used to 
generate transgenic plants in any type of plant, i.e., mono 
cots or dicots. Preferably, transgenic plants of the invention 
are crop plants, such as tobacco, hemp, or food crops, such 
as tomato, corn, soy, Wheat, rice, etc. Transgenic plants of 
the invention may also be ?oWering plants, such as 
carnations, roses, and the like. The skilled practitioner, using 
methods knoWn in the art, can readily transform any plant 
type using the isolated DNA molecules and vectors of the 
invention. For example, a transgenic plant of the invention 
can be produced usingAgrobacterium tumefaciens mediated 
DNA transfer, preferably With a disarmed T-DNA vector, 
electroporation, direct DNA transfer, and particle bombard 
ment. Techniques are Well knoWn in the art for introducing 
nucleic acids into monocots as Well as dicots, as are the 
techniques for culturing such plants and plant tissues and 
regenerating them. 
The MMV Sgt promoter constructs of the present inven 
tion can be used to generate transgenic plants, seeds or 
protoplasts, and may be used to drive expression of a gene 
or genes of interest in any plant tissue, e.g., roots, stems, 
leaves, ?oWers, stems, pollen, or seeds. 
The studies presented herein demonstrate that the MMV 
Sgt promoter is a strong constitutive promoter capable of 
directing foreign gene expression in heterologous systems, 
including transgenic plants, at a greater level than that of 
both CaMV35S and CAMV 19S promoters. There is very 
limited sequence homology betWeen the MMV Sgt promoter 
With other caulimovirus promoters, although they are func 
tionally analogous. 
The present MMV Sgt promoter and fragments of the 
promoter are useful for generating transgenic plants and, for 
example, studying plant metabolism. For metabolic 
engineering, expression of multiple genes in a single cell 
may be necessary to gain an understanding of plant meta 
bolic pathWays. The use of different promoters having 
non-homologous sequences may be useful in order to avoid 
genetic instability due to recombination betWeen identical 
promoter sequences. Thus, the present MMV Sgt promoter 
constructs Will lend themselves handily to such studies, 
When used to drive the expression of a plant metabolic gene 
or genes in conjunction With other chimeric constructs 
driven by other, nonhomologous promoters. 
The present invention is illustrated by the folloWing 
examples, but is not intended to be limited thereby. 
EXAMPLE 1 
Protoplasts, Plants and EnZymes 
Isolation of protoplasts from tobacco cell suspension 
cultures (Xanthi ‘Brad’) and electroporation of protoplasts 
With supercoiled DNA containing a promoter fragment fused 
With the GUS gene Were done essentially as described by 
[38]. Tobacco plants (Nicotiana tabacum cv. Samsun NN) 
Were used for plant transformations. Restriction enZymes, 
antibiotics, components of plant tissue culture medium, and 
RNA isolation kits Were purchased from commercial 
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sources. Nitrocellulose and Nytran membranes Were 
obtained from Schleicher & Schuell, USA. 
Isolation of a MMV Sgt Promoter and Modi?cation of its 
DNA Sequence 
A full-length genomic clone of mirabilis mosaic virus 
(MMV) in plasmid pMMV-B10 [1] has been fully 
sequenced (Maiti, unpublished results), and Was used as 
template for PCR reactions. A 1012 bp segment (coordinates 
4829 to 5840 of the MMV genome) Was selected for 
promoter deletion analysis. The fragment Was isolated as a 
BamHI-HindIII fragment by PCR using the folloWing prim 
ers: ForWard primer: 5‘-GCG GGC GGATCC GAAAAA 
CGG AAA CCG TTA-3‘ (SEQ ID NO:3) and (ii) Reverse 
primer: 5‘-ATG CAG AAG CTT TTG TTG TGT CTT TAC 
CGG-3‘ (SEQ ID NO:4). Promoter sequences in the primers 
are shoWn in bold and restriction enZymes sites are under 
lined. The PCR-fragment Was gel-puri?ed using QIAGEN 
procedure (Valencia, Calif. 91355, USA). After digestion 
With BamHI and HindIII, the PCR fragment Was cloned into 
the corresponding sites of pBS(KS+) (Strategen, La Jolla, 
Calif. 92037, USA). The plasmid Was designated as 
pBSMS1011. 
Modi?cation of EcoRl site to a Smal site 
The pBSMS1011 has an EcoRI site at the MMV genome 
coordinate 5345. This EcoRI site located 52 bp upstream of 
a TATA sequence Was modi?ed With a SmaI site using tWo 
primers having the folloWing sequences: ForWard primer has 
sequence 5‘-AATTACCCGGGC-3‘ (SEQ ID NO:5) and 
reverse primer has sequence 5‘-AATTGCCCGGGT-3‘ (SEQ 
ID NO:6). These tWo primers Were mixed in a 1:1 molar 
ratio and alloWed to anneal by sloW cooling (20 C./min) from 
94° to 24° under a programmed PCR cycle. The plasmid 
pBSMS1011 Was digested With EcoRI and ligated With the 
‘EcoRI to SmaI’ adapter, folloWed by transformation. The 
resulting plasmid Was designated as pBSMS1011E. This 
change inserted 12 additional nucleotides (5‘ 
AATTACCCGGGC-3‘) (SEQ ID NO:5) into the promoter 
sequence (FIG. 1). 
DNA Sequencing 
Automated DNA sequencing Was done With an Applied 
Biosystem ABI Prism 310 Genetic AnalyZed (Perkin Elmer) 
using ABI Prism Dye terminator cycle sequencing ready 
reaction kit containing Ampli Taq DNA polymerase. Primer 
extension Was carried out by using PCR (denaturation 96° C. 
for 30 seconds; annealing 50° C. for 30 seconds and exten 
sion at 60° C. for four minutes; 27 cycles ?ve nmole 
template DNA and 50 pmole speci?c primer in 20 pl of 
reaction mix. After PCR excess terminators Were removed 
by 95% ethanol Wash. The pellet containing the puri?ed 
extension products Was ?nally suspended in 25 pl of tem 
plate suspension reagent (P/N401674; Perkin Elmer), 
vortexed, and heat-denatured at 95° C. for tWo minutes 
before loading into a capillary tube. 
Glucuronidase (GUS) Assay 
Fluorometric GUS assays to measure GUS activity in 
plant tissue or protoplasts extracts and histochemical GUS 
staining to localiZe the distribution of GUS activity in plants 
Were performed according to Jefferson et al., [42], as 
described earlier [18]. Protein in plant extract Was deter 
mined according to the method of Bradford [43], using BSA 
as a standard. 
RNA Extraction, RNA Dot Blot and Northern Blot Analysis 
Total RNA Was prepared from transformed protoplasts 
containing individual MMV Sgt promoter constructs by 
extracting With guanidine thiocyanate [44] solution using an 
Ambion RNA extraction kit (RNAqueous), as described 
earlier [22]. The RNA dot blot and Northern blot analysis 
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Were performed using a 32P-labelcd GUS-probe essentially, 
as described previously [22]. 
Determination of Transcriptional Start Site (TSS) of MMV 
Sgt Promoter 
The transcriptional start site Was determined by primer 
extension analysis. The extension product Was separated on 
a 7.5% polyacrylamide gel containing 7M-urea [45]. 
Sequencing reactions Were carried out according to Sanger 
et al. [39], using Sequenase Version 2.0, USB, as described 
earlier [22]. 
EXAMPLE 2 
Construction of Vectors for Transient Expression Experi 
ment in Protoplasts 
Aseries of promoter fragments used in construction of the 
plant transformation vector With the subgenomic promoter 
of MMV Were designed to study the in?uence of upstream 
and doWnstream sequences With respect to the TATA box on 
promoter activity. The de?ned MMV Sgt promoter 
sequence, of length as indicated (in FIG. 1) Was ampli?ed by 
PCR using pBSMS1011E as template and appropriately 
designed primers to tailor an EcoRI site at the 5‘-end and 
HindIII site at the 3‘-end of the ampli?ed products. PCR 
ampli?cation Was carried out for 31 cycles under the fol 
loWing standard conditions: denaturation (92° C. for 1 
minute), annealing (55° C. for 1 minute), extension (72° C. 
for 2 minutes) using ELONGASE enZyme mix (recombinant 
high ?delity TaqDNA polymerase mix With proof reading 
3‘—5‘ exonuclease activity from Gibco-BRL, Maryland, 
USA. Each of PCR ampli?ed fragments 1 to 25 Was 
restricted With EcoRI and HindIII; the restricted fragments 
Were gel-puri?ed and cloned into the corresponding sites of 
pUC119 vector and sequenced by dideoxy chain terminator 
method [39] using synthetic primers. 
Subcloning of the MMVSgt Promoter Fragments from 
pUC119 into pUCPMAGUS Vector 
The sequence of each of the MMV Sgt promoter frag 
ments cloned in pUC119 Was veri?ed before subcloning to 
pUCPMAGUS, a protoplast expression vector (Dey and 
Maiti, 1999). MMV Sgt promoter fragments Were individu 
ally gel puri?ed from the corresponding pUC119 clone after 
restriction digestion With EcoRI and HindIII and subcloned 
into the corresponding sites of pUCPMAGUS (Dey and 
Maiti, 1999). The folloWing deletion plasmids Were devel 
oped (see FIG. 2). The 5‘ and 3‘ coordinates of the promoter 
fragment With respect to TSS are given in parenthesis: 
pPMS1GUS (—646 to +27 (SEQ ID NO:14)), pPMS2GUS 
(—606 to +27(SEQ ID NO:15)), pPMS3GUS (—556 to +27 
(SEQ ID NO:16)), pPMS4GUS (—506 to +27(SEQ ID 
NO:17)), pPMS5GUS (—456 to —27(SEQ ID NO:9)), 
pPMS6GUS (—406 to +27(SEQ IN NO:18)), pPMS7GUS 
(—356 to +27(SEQ ID NO:19)), pPMS8GUS (—306 to +27 
(SEQ ID NO:2)), pPMS9GUS (—256 to +27(SEQ ID 
NO:20)), pPMS10GUS (—206 to +27(SEQ ID NO:21)), 
pPMS11GUS (—156 to +27(SEQ ID NO:22)), pPMS12GUS 
(—117 to +27(SEQ ID NO:23)), pPMS13GUS (—94 to +27 
(SEQ ID NO:24)), pPMS14GUS (—74 to +27(SEQ ID 
NO:25)), pPMS15GUS (—44 to +27(SEQ ID NO:26)), 
pPMS16GUS (—456 to —74(SEQ ID NO:27)), pPMS17GUS 
(—456 to —19(SEQ ID NO28)), pPMS18GUS (—306 to 
+50(SEQ ID NO:29)), pPMS19GUS (—306 to +77(SEQ ID 
NO:30)), pPMS20GUS (—306 to +127(SEQ ID NO:31)), 
pPMS21GUS (—306 to +177(SEQ ID NO:32)), 
pPMS22GUS (—306 to 227(SEQ ID NO:33)), pPMS23GUS 
(—306 to 227(SEQ ID NO:34)), pPMS24GUS (—306 to 
+327(SEQ ID NO:35)), pPMS25GUS (—306 to +377(SEQ 
ID NO:36)), 
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Construction of Vectors With MMV Sgt Promoter Fragments 
for Expression of Genes in Plants 
The MMV Sgt promoter fragments from constructs 
pPMS5GUS (—456 to +27), pPMS8GUS (—306 to +27) and 
pPMS17GUS (—456 to —19) Were isolated by EcoRI and 
HindIII digestion folloWed by gel puri?cation and cloned 
into the plant expression vector pKYLX71 [40] individually 
at its unique restriction EcoRI and HindlII sites that ?ank the 
promoter. The folloWing plant gene expression vectors Were 
developed: pKMS5, pKMS8 and pKMS17. These plant gene 
expression vectors have multiple cloning sites (MCS): 
5‘—HindIII-BamHI-Xhol-Sstl-XbaI-3‘) With the folloWing 
unique sites: HindlII, XhoI, SstI and Xbal. The reporter GUS 
gene from pBSGUS Was inserted as an XhoI-SstI fragment 
into these pKYLX-based expression vectors separately, and 
the resulting plasmids Were designated as pKMSSGUS, 
pKMS8GUS and pKMS17GUS. 
Isolation of CaMV 19S Promoter, and Construction of 
Vectors With the CaMV 19S and 35S Promoters for Tran 
sient and Stable Expression of Genes in Plant Cells 
A 990 bp SalI to SstI fragment containing the CaMV 19S 
promoter Was isolated from pCaMV10, a full length 
genomic clone of the CaMV strain CM1841 This SalI to 
SstI restricted fragment, corresponding to the CaMV 
genomic coordinates 4833 to 5822, Was gel-puri?ed and 
cloned into the corresponding sites of pBS(KS+). The result 
ing plasmid Was designated as pBSCaMV (4833—5822). An 
internal EcoRI site in the pBSCaMV (4833—5822) corre 
sponding to the CaMV genomic coordinate 5646 Was modi 
?ed to SmaI site using the synthetic adaptor, and the 
modi?ed plasmid Was designed pBSCaMV (4833—5822)E. 
Using this clone as a template, a 412 bp CaMV 19S 
promoter fragment (CaMV coordinates 5380 to 5773) Was 
isolated by PCR With the designed primers. The forWard 
primer, 5‘CAAGAATTCGTTAAC 
AAGCTGCAGAAAGGAATTACC-3‘ (SEQ ID NO:7), 
contains EcoRI and HpaI sites (underlined) and CaMV 
sequence (shoWn in bold). The reverse primer 
5‘-CTTAAGCTTGCTTGGAGGTCTGATTTT-3‘ (SEQ ID 
NO:8), has a HindIII site (underlined) and CaMV sequence 
(indicated in bold). The PCR-ampli?ed promoter fragment 
has EcoRI and HpaI sites at the 5‘-end and a HindIII site at 
the 3‘-end to facilitate cloning. The fragment has the general 
structure 5‘-EcoRI-HpaI-promoter sequence SmaI-TATA 
promoter sequence-HindIII-3‘. 
The PCR ampli?ed CaMV 19S promoter fragment (412 
bp) Was cloned into the corresponding EcoRI-HindlII sites 
of the vector pUCPMAGUS [22] for the transient expression 
in protoplasts, and also into the corresponding sites of the 
vector pKYLXGUS for stable transgene expression. The 
resulting expression vectors Were named pPCaSGUS and 
pKCaSGUS, respectively. 
Similarly, the CaMV 35S promoter (—940 to +27 from 
TSS; corresponding to the CaMV genomic coordinates 6493 
to 7459), Was cloned as an EcoRI-HindIII fragment into the 
corresponding sites of the transient expression vector 
(pUCPMAGUS) for the expression of GUS gene in proto 
plasts. The resulting plasmid Was named pPCa35S-GUS. 
The GUS reporter gene Was inserted as an XhoI-SstI frag 
ment into the corresponding sites of PKYLX71 [40]. In the 
resulting plant expression vector pKCa35S-GUS, the GUS 
reporter gene is directed by the CaMV 35S promoter 
(coordinates —940 to +27 from TSS). 
EXAMPLE 3 
Transient Expression Analysis of MMV Sgt Promoter Dele 
tion Constructs in a Protoplast System 
Isolation of protoplasts from the tobacco cell suspension 
cultures (Xanthi ‘Brad’) and electroporation of protoplasts 
US 6,930,182 B1 
15 
With supercoiled DNA containing the MMV Sgt promoter 
fragment and GUS gene Were done essentially as described 
earlier (Maiti et al., 1998). Electroporation Was carried out 
by using the GenePulser II Apparatus (BioRad) With the 
Capacitance Extender II (Model 165-2107). An aliquot of 
800 1 containing 2X10 6 protoplasts in an electroporation 
cuvette (0.4 cm electrode gap) Was electroporated (200V 
used for charging 960 F capacitance for 40 milliseconds) 
With 5 g of supercoiled plasmid DNA containing GUS 
reporter gene. After 20 hours, tWo billion electroporated 
protoplasts Were individually harvested for GUS assay. A 
deletion analysis scheme of MMV Sgt promoter is shoWn in 
FIG. 3A. A series of 5‘-and 3‘-end deleted promoter frag 
ments (total 25 fragments) Were included in order to map the 
optimum boundaries required for maximal expression from 
promoter/leader region and also to analyZe the in?uence of 
the upstream and doWnstream cis-sequence With respect to 
the TATA box. The designed deletion promoter fragments 1 
to 25 (as shoWn in FIG. 3A) Were ampli?ed by PCR and 
cloned into protoplasts expressing vector pUCPMAGUS as 
in Example 2. Results of the expression analysis of the 
MMV Sgt promoter are shoWn in FIG. 3B. In a transient 
expression assay, the construct pPMS8GUS, Which contains 
the promoter fragment (coordinates —306 to +27 from TSS) 
gives maximum activity. The construct pPMS5GUS, 
pPMS7GUS, pPMS10GUS and pPMS17GUS shoWed 76%, 
70%, 65% and 45% of GUS activity compared to the 
constructs pPMS8GUS (With highest GUS activity). Con 
struct pPMS16GUS, Which is devoid of the TATA box, 
shoWed very little of GUS activity indicating the importance 
of TATA element in MMV Sgt promoter activity. A 320 bp 
MMV Sgt promoter/leader fragment, sequence —306 to +27 
from TSS, Was found to be sufficient for maximal GUS 
expression. Constructs pPMS5GUS, pPMS8GUS and 
pPMS17GUS Were selected for their stable expression 
analysis in transgenic tobacco plants (see Example 4). 
EXAMPLE 4 
Stable Expression Analysis of MMV Sgt Promoter in Trans 
genic Plants 
The MMv Sgt promoter fragments from constructs 
pPMS5GUS (—456 to +27), pPMS8GUS (—306 to +27) and 
pPMS17GUS (—456 to —19) Were isolated by EcoRI and 
HindIII digestion folloWed by gel puri?cation and cloned 
into the plant expression vector pKYLX71 (Schardl et al., 
1987) separately at its unique EcoRI and HindIII restriction 
sites that ?ank the promoter. The folloWing plant expression 
vectors Were developed: pKMS5, pKMS8 and pKMSl7. 
These plant expression vectors have multiple cloning sites 
(MCS): 5‘—HindIII-BamHI-XhoI-SstI-XbaI-3‘) With the fol 
loWing unique sites: HindIII, XhoI, SstI and XbaI. The 
reporter GUS gene from pBSGUS as XhoI-SstI fragment 
Was inserted into these pKYLX-based plant expression 
vectors separately and the resulting plasmids Were desig 
nated as pKMS5GUS, pKMS8GUS and pKMS17GUS. 
On average, tWelve to fourteen independent primary 
transgenic tobacco (Nicotiana tabacum cv. Samsun NN) 
lines (R0 progeny) Were developed for each of these con 
structs and groWn under greenhouse condition. Leaf extract 
from these R0 plants Was used for ?uorometric GUS assays. 
Analysis of these lines from R0 progeny shoWed that the 
GUS expression level in transgenic plant lines obtained from 
pKMSSGUS construct is maximum folloWed by plant lines 
obtained from construct pKMS8GUS (82% of pKMS5GUS 
activity) and pKMS17GUS (48% of pKMS5GUS activity), 
(data not presented for R0 plants)). Seeds Were collected 
from self-fertiliZed independent Ro lines. Segregation analy 
sis for the marker gene (KanR) Were performed. About 8 to 
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9 individual R1 transgenic lines shoWing expected segrega 
tion ratio (KanR:KanS=3:1) for the marker KanR for each 
construct Were further analyZed. Whole seedling extract Was 
used for ?uorometric GUS assays. The GUS activity in R1 
transgenic plants (FIG. 3B). is hoWever 5 to 8 times higher 
than the GUS activity obtained in R0 plants. Transgenic 
plants (R1 progeny) developed for construct pKMS5GUS 
shoWed highest activity folloWed by pKMS8GUS (—306 to 
+27, 58% of pKMS5GUS) and pKMS17GUS (—456 to —19, 
32% of pKMS5GUS). Histocherical GUS staining Was 
carried out With Whole seedlings separately from these three 
constructs shoWed comparable intensity of GUS activity 
(FIG. 4). 
EXAMPLE 5 
Comparative Expression Analysis of MMV Sgt Promoter 
With MMV FLt, CaMV 35S and CaMV19S Promoters. 
In pPCaSGUS or pKCaSGUS, the GUS reporter gene is 
directed by the CaMV sub-genornic transcript promoter 
sequence (corresponding to CaMV genomic coordinates 
5380 to 5773). The MMV Sgt promoter constructs 
pKMS5GUS, pKMS8GUS and pKMS17GUS Were com 
pared With the CaMV promoters (19S and 35S) and three 
MMV FLt promoter constructs pKMlGUS, pKM12GUS 
and pKM13GUS (Dey and Maiti 1999a) both in protoplasts 
assay (FIG. 5A), and transgenic plant expression analysis 
(FIG. 5B). In protoplast assays, the MMV Sgt promoter 
fragments in constructs, pPMS5GUS and pPMS8GUS, 
shoWed more activity (5 and 7 fold, respectively) as com 
pared to pPCaSGUS, and about tWo fold greater activity 
than CaMV 35S promoter (FIG. 5A). MMV Sgt promoter in 
pPMS5GUS and pPMS8GUS shoWed comparable activity 
With MMV FLt promoter in pPM12GUS and pPM13GUS 
(FIG. 5A), suggesting that the strength of the MMV Sgt 
promoter is comparable to or greater that of the MMV FLt 
promoter. The CaMV 19S is a Weakpromoter, as compared 
to the 35S promoter [14]. This suggests that the MMV Sgt 
promoter may have a different functional mechanism, as 
compared to the CaMV 19S promoter. 
For stable transformation assays, a number of indepen 
dent transgenic tobacco (Nicotiana tabacum cv. Samsun 
NN) lines Were generated. Flurometric GUS assays Were 
carried out With Whole seedling (R1 progeny) extracts. The 
results of transgenic plant analysis shoWn in FIG. 5B. In 
protoplast assays the GUS expression With construct 
pPMS8GUS Was highest. Three MMV Sgt promoter frag 
ments analyZed in transgenic plants shoWed strong GUS 
expression compared to both CaMV 19S and 35S promoter. 
The level of expression of GUS reporter gene in 
pKMS5GUS (highest expressing construct) is about 8 fold 
more than CaMV 19S promoter and 2 fold stronger than 
CaMV 35S promoter (FIG. 5B). 
The relative intensity of histochemical GUS staining of 
the young seedlings developed for the constructs, 
pKMS5GUS and pKMS8GUS, pKMS17GUS shoWed 
strong promoter activity compared to pKCaSGUS (With 
CaMV35S promoter) and pKCa35SGUS (With CaMV 35S 
promoter) (FIG. 4). 
EXAMPLE 6 
Constitutive Expression of MMVSgt Promoter in Different 
Parts of Transgenic Seedlings 
The MMV Sgt promoter activity Was measured in various 
tissues during seedling (R1 progeny, second generation) 
development. Transgenic seedlings Were aseptically groWn 
on MS-agar medium in presence of kanamycin (240pg/ml) 
supplemented With 3% sucrose. Seedlings from the inde 
pendent lines shoWing segregation ratio (KanS:Kan’=1:3) for 
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the Kan’ gene Were selected for further analysis. Eight 
independent lines for each construct Were examined. The 
relative expression of GUS reporter gene in 28 day (4 
Weeks) old seedlings (R1 progeny) transformed With 
pKMS5GUS, pKMS8GUS and pKMS 17GUS Were moni 
tored by ?uorometric GUS assay and by histochemical 
staining. A relative level of GUS activity in roots, leaves and 
stems is shoWn in FIG. 5. On average GUS activity Was 
maximum in roots folloWed by in leaves and stems in 
seedling developed for pKMS5GUS. Seedlings developed 
With pKM8GUS shoWed more activity in leaves folloWed by 
in roots and stems. Seedlings developed for construct 
pKMS15GUS shoWed more uniform GUS activity in dif 
ferent parts of seedlings although slightly more activity in 
leaves folloWed by stems and roots (FIG. 5). 
EXAMPLE 7 
Histochemical LocaliZation of GUS Activity in Transgenic 
Plants 
MMV Sgt promoter activity Was measured in various 
tissues during seedling (R1 progeny, second generation) 
development. The level of intensity of GUS activity Was 
measured by histochemical staining of hand-cut fresh tissue 
sections of various organs of transgenic plants developed for 
the construct pKMS5GUS shoWn in FIG. 8. Strong GUS 
activity Was detected in vascular tissues in midrib and lateral 
secondary veins of matured leaves (FIG. 8B), in young 
leaves and in the apical meristem region of young seedlings 
(FIG. 8D). Cross section of stems (FIG. SI) and petioles 
(FIG. 8G) shoWed intense staining of the phloem cells. 
Strong GUS accumulation Was detected in vascular tissues 
of roots and root tips (FIG. 8C). The non-transformed 
tobacco shoWed no GUS staining in mature leaves (FIG. 
8A), in root tissues (data not shown) or in cross sections of 
stems FIG. 8H), and petioles (FIG. 8F). Histochemical GUS 
staining of different ?oral tissues Was performed. The petal 
(corolla) portion of the ?oWer shoWed light GUS staining 
(FIG. 80). Another, plant section containing pollen grains 
exhibited intense GUS activity (FIG. 8N). The stigma and 
style portion of the ?oWer shoWed much less GUS staining 
(FIG. 8M). The longitudinal cross-section of the ?oWer 
pedicel and ovary (6 days after opening of the ?oWer) 
shoWed intense staining of the pedicel and the basal vascular 
part of the ovary (FIG. 8L). Differential GUS staining in 
various ?oral organs may be due to tissue speci?c expression 
of MMV Sgt promoter. A similar tissue speci?c expression 
pattern Was documented for the FLt promoter from CaMV 
[30], FMV [18], PCISV [21] and MMV [22,23]. 
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SEQUENCE LISTING 
<l60> NUMBER OF SEQ ID NOS: 37 
<2 10> 
<2ll> 
<2 12> 
SEQ ID NO 1 
LENGTH: 1024 
TYPE: DNA 
ORGANISM: Mirabilis mosaic virus (MMV) 
<400> SEQUENCE: l 
gaaaaacgga aaccgttaca ggtaaagttg aagaaagatc aggtatggat ctggacgcaa 60 
21 
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tcagatactg attacgttaa 
ctaccaaaga aagaagacag 
ggagtcctta aggcccaaac 
acattcaaac cagcagaatt 
caggtgatta ctaaatttag 
aatgtaaatc ttttaaaagg 
aggctaataa gatggcaaat 
ggagaacaaa atgtgctggc 
ggaaacgtca tccatgacga 
caaatgaaaa ttccacacaa 
caggaaaaac aaaaaccagt 
atcctcttgg tagaactcga 
ggaagtttag accaggaagg 
gatggtaaag acggctcaaa 
aacttggttc caagtcctga 
gaaagtgggt tgtatatccc 
acaa 
<2 10> SEQ ID NO 2 
<2ll> LENGTH: 333 
<2 12> TYPE: DNA 
aaagataaag 
tttaattatt 
cactgaaggt 
gaattaccat 
tatttatcta 
atttatgaat 
gtggttttca 
tgattatctc 
ctaaacctgc 
aacacatcct 
aatggaaaaa 
ttctatcaga 
ctctgcctca 
tccgttaaac 
gaaggatgaa 
cacgactagt 
<2 13> ORGANISM: Mirabilis mosaic 
<400> SEQUENCE: 2 
gttttacagt caggacagat 
ctggtgacag taaacaggga 
ttaaggtgga ccacctaaaa 
tacccgggca attccacaat 
ctataaaaac tgggtttttc 
ggggggaatt aaatcaaaaa 
<2 10> SEQ ID NO 3 
<2ll> LENGTH: 30 
<2 12> TYPE: DNA 
aatgtaaatc 
aggctaataa 
ggagaacaaa 
ggaaacgtca 
caaatgaaaa 
caggaaaaac 
aaaggattaa 
gaaactgatg 
gaagaattaa 
agtaatgaga 
acccctgttt 
aaaaagatta 
cattacacct 
accagagaat 
catttttcgg 
tttttcaaag 
gagcttcagg 
aaacaaatca 
cactctaaac 
cctgatgctt 
tccaagaaag 
ccggttgcaa 
virus (MMV) 
ttttaaaagg 
gatggcaaat 
atgtgctggc 
tccatgacga 
ttccacacaa 
aaa 
<2 13> ORGANISM: Artificial Sequence 
<220> FEATURE: 
ttaattttcc aaaactttat 
cttctgatca cttttggggt 
tctgcaggta ttcttcagga 
aagaattact agcggtaaaa 
gttttacagt caggacagat 
ctggtgacag taaacaggga 
ttaaggtgga ccacctaaaa 
tacccgggca attccacaat 
ctataaaaac tgggtttttc 
ggggggaatt aaatcaaaaa 
ctctaaggat caaagaaaag 
gcatttacgc tgaactaact 
ctagtccaca gcaaacggct 
tgggaaaaag cataacggag 
ttgtcagttt acgaaaaact 
acggctccgg taaagacaca 
atttatgaat aaaaagatta 
gtggttttca cattacacct 
tgattatctc accagagaat 
ctaaacctgc catttttcgg 
aacacatcct tttttcaaag 
<223> OTHER INFORMATION: Chemically synthesized forward primer 
<400> SEQUENCE: 3 
9C99<3Cqqat Ccgaaaaacg 
<2 10> SEQ ID NO 4 
<2ll> LENGTH: 30 
<2 12> TYPE: DNA 
gaaaccgtta 
<2 13> ORGANISM: Artificial Sequence 
<220> FEATURE: 
<223> OTHER INFORMATION: Chemically synthesized reverse primer 
<400> SEQUENCE: 4 
atgcagaagc ttttgttgtg tctttaccgg 
120 
180 
240 
300 
360 
420 
480 
540 
600 
660 
720 
780 
840 
900 
960 
1020 
1024 
60 
120 
180 
240 
300 
333 
30 
30 










